Form 4: Director Meghan V. Joyce Reports Stock Transactions in Guardant Health, Inc.

Director Meghan V. Joyce reported the vesting of restricted stock units into 66 shares of Guardant Health, Inc. common stock on May 4, 2025.

Summary

• On May 4, 2025, Meghan V. Joyce, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
• The transaction involved the vesting of 66 restricted stock units, which converted into 66 shares of common stock.
• Following the transaction, Ms. Joyce directly owns 7,846 shares of Guardant Health, Inc. common stock.
• The restricted stock units vested according to a schedule that began on August 4, 2022, with 25% vesting initially and the remaining 75% vesting in monthly installments over three years.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, which carries a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it is a routine vesting of previously granted equity.

Key Dates

Keywords

Guardant Health, Director, Stock Transaction, Restricted Stock Units, Form 4, Beneficial Ownership